(Reuters) -Amazon.com has put in a last-minute offer to buy all of short-form video app TikTok, the New York Times reported on Wednesday, citing three
Year: 2025
Exclusive-Safran to win EU approval for $1.8 billion Collins deal, sources say
By Foo Yun Chee BRUSSELS (Reuters) -French engine and aircraft equipment maker Safran is set to secure conditional EU antitrust approval for its $1.8 billion
Mexico will not enter a tariff tit-for-tat with US, Sheinbaum says
MEXICO CITY (Reuters) -Mexican President Claudia Sheinbaum said on Wednesday that Mexico doesn’t plan to impose tit-for-tat tariffs on the United States, ahead of President
Trump tariffs won’t derail fall in European inflation, ECB’s Villeroy says
PARIS (Reuters) – The U.S. administration’s tariff hikes should not derail an ongoing decline in inflation in Europe, ECB policymaker Francois Villeroy de Galhau said
Big Tobacco targets Trump in hope – and fear – of change
By Emma Rumney LONDON (Reuters) -Big tobacco companies like British American Tobacco are lobbying U.S. President Donald Trump’s administration to crack down on illegal vapes,
Toyota says it will maintain operations despite US tariffs
TOKYO (Reuters) – Toyota will keep running its operations as it has been and focus on bringing down fixed costs, it said on Monday, not
Gold sails above $3,100 to uncharted territory as US tariffs approach
By Anjana Anil and Anushree Mukherjee (Reuters) – Gold prices soared to record levels above $3,100 per ounce in a rally marking one of the
Tariff-hit firms may need business turnaround financing, Japan’s bank lobby chair says
By Anton Bridge and Miho Uranaka TOKYO (Reuters) – Japanese banks may need to offer business turnaround support to companies hit by tariffs imposed by
Glass Lewis recommends votes “against” CEO pay at Goldman Sachs
(Reuters) – Proxy adviser Glass Lewis recommended investors cast advisory votes “against” the pay of top Goldman Sachs executives, citing the Wall Street bank’s “continued
Top vaccine official Peter Marks forced out at FDA, WSJ reports
(Reuters) -The U.S. Food and Drug Administration’s top vaccine official, Peter Marks, has been pushed out, the Wall Street Journal reported on Friday. Marks, who